LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Replicate Assay Well Timepoint Timepoint Unit Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value
MCF 10A Ruxolitinib
3.33
uM
LJP5
 3
O14
 72
hr
 1694 10700 11168 0.9581 0.9688
MCF 10A Ruxolitinib
10
uM
LJP5
 1
O13
 72
hr
 1694 9607 11042 0.8700 0.8996
MCF 10A Ruxolitinib
10
uM
LJP5
 2
O13
 72
hr
 1694 8748 11099 0.7881 0.8319
MCF 10A Ruxolitinib
10
uM
LJP5
 3
O13
 72
hr
 1694 9533 11168 0.8536 0.8869
MCF 10A Momelotinib
0.04
uM
LJP5
 1
P12
 72
hr
 1694 10522 11042 0.9529 0.9646
MCF 10A Momelotinib
0.04
uM
LJP5
 2
P12
 72
hr
 1694 10471 11099 0.9434 0.9575
MCF 10A Momelotinib
0.04
uM
LJP5
 3
P12
 72
hr
 1694 10636 11168 0.9523 0.9644
MCF 10A Momelotinib
0.12
uM
LJP5
 1
P11
 72
hr
 1694 10129 11042 0.9173 0.9372
MCF 10A Momelotinib
0.12
uM
LJP5
 2
P11
 72
hr
 1694 10059 11099 0.9063 0.9287
MCF 10A Momelotinib
0.12
uM
LJP5
 3
P11
 72
hr
 1694 10230 11168 0.9160 0.9365
MCF 10A Momelotinib
0.37
uM
LJP5
 1
P10
 72
hr
 1694 9368 11042 0.8484 0.8820
MCF 10A Momelotinib
0.37
uM
LJP5
 2
P10
 72
hr
 1694 9605 11099 0.8654 0.8961
MCF 10A Momelotinib
0.37
uM
LJP5
 3
P10
 72
hr
 1694 9258 11168 0.8290 0.8667
MCF 10A Momelotinib
1.11
uM
LJP5
 1
P09
 72
hr
 1694 8953 11042 0.8108 0.8507
MCF 10A Momelotinib
1.11
uM
LJP5
 2
P09
 72
hr
 1694 9106 11099 0.8204 0.8592
MCF 10A Momelotinib
1.11
uM
LJP5
 3
P09
 72
hr
 1694 8750 11168 0.7835 0.8284
MCF 10A Momelotinib
3.33
uM
LJP5
 1
P08
 72
hr
 1694 7508 11042 0.6799 0.7341
MCF 10A Momelotinib
3.33
uM
LJP5
 2
P08
 72
hr
 1694 7992 11099 0.7200 0.7719
MCF 10A Momelotinib
3.33
uM
LJP5
 3
P08
 72
hr
 1694 8037 11168 0.7196 0.7722
MCF 10A Momelotinib
10
uM
LJP5
 1
P07
 72
hr
 1694 2581 11042 0.2337 0.1684
MCF 10A Momelotinib
10
uM
LJP5
 2
P07
 72
hr
 1694 2809 11099 0.2531 0.2050
MCF 10A Momelotinib
10
uM
LJP5
 3
P07
 72
hr
 1694 2627 11168 0.2352 0.1749
MCF 10A Fedratinib
0.04
uM
LJP5
 1
L06
 72
hr
 1694 11338 11042 1.0268 1.0196
MCF 10A Fedratinib
0.04
uM
LJP5
 2
L06
 72
hr
 1694 10727 11099 0.9664 0.9750
MCF 10A Fedratinib
0.04
uM
LJP5
 3
L06
 72
hr
 1694 11353 11168 1.0165 1.0121